| Dr Patrick Christopher Anderl, MD | |
|
2510 Bellevue Medical Center Dr, Suite 200, Bellevue, NE 68123-1520 | |
| (402) 595-1978 | |
| (402) 595-1296 |
| Full Name | Dr Patrick Christopher Anderl |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 2510 Bellevue Medical Center Dr, Bellevue, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477968972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 7258 (Nebraska) | Secondary |
| 207Q00000X | Family Medicine | 29001 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Home Care | Bellevue, NE | Home health agency |
| Hrs Of Nebraska, Inc. | Omaha, NE | Home health agency |
| Bellevue Medical Center | Bellevue, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
The 28th Annual Ruth K. Palmer Research Symposium will address "Inequities in Health: From Cells to Community."
Not surprisingly, the plan has drawn complaints from the left about cuts to Social Security and Medicare, and from the right about defense cuts and tax increases. But the senators are right about the need to simplify and broaden the tax code and to put entitlements on a sustainable footing without slashing aid to the most vulnerable.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
Obama Administration officials on Friday unveiled the U.S. government's strategy to achieve the U.N. Millennium Development Goals by 2015 during a meeting at the U.N. Foundation "that was closed to the press," Washington Post's "Checkpoint Washington" blog reports.
NuGEN Technologies, Inc., an innovator in genomic sample preparation, makes a dramatic entry into the next-generation sequencing (NGS) applications market with the strategic addition of a team of experts in NGS, the opening of a new Seattle research facility, and — by year's end — the launch of a simplified sample preparation kit capable of working from reduced starting material for next-generation RNA-Seq.
› Verified 5 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
The 28th Annual Ruth K. Palmer Research Symposium will address "Inequities in Health: From Cells to Community."
Not surprisingly, the plan has drawn complaints from the left about cuts to Social Security and Medicare, and from the right about defense cuts and tax increases. But the senators are right about the need to simplify and broaden the tax code and to put entitlements on a sustainable footing without slashing aid to the most vulnerable.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
Obama Administration officials on Friday unveiled the U.S. government's strategy to achieve the U.N. Millennium Development Goals by 2015 during a meeting at the U.N. Foundation "that was closed to the press," Washington Post's "Checkpoint Washington" blog reports.
NuGEN Technologies, Inc., an innovator in genomic sample preparation, makes a dramatic entry into the next-generation sequencing (NGS) applications market with the strategic addition of a team of experts in NGS, the opening of a new Seattle research facility, and — by year's end — the launch of a simplified sample preparation kit capable of working from reduced starting material for next-generation RNA-Seq.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Christopher Anderl, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: () - | Dr Patrick Christopher Anderl, MD 2510 Bellevue Medical Center Dr, Suite 200, Bellevue, NE 68123-1520 Ph: (402) 595-1978 |
News Archive
The 28th Annual Ruth K. Palmer Research Symposium will address "Inequities in Health: From Cells to Community."
Not surprisingly, the plan has drawn complaints from the left about cuts to Social Security and Medicare, and from the right about defense cuts and tax increases. But the senators are right about the need to simplify and broaden the tax code and to put entitlements on a sustainable footing without slashing aid to the most vulnerable.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
Obama Administration officials on Friday unveiled the U.S. government's strategy to achieve the U.N. Millennium Development Goals by 2015 during a meeting at the U.N. Foundation "that was closed to the press," Washington Post's "Checkpoint Washington" blog reports.
NuGEN Technologies, Inc., an innovator in genomic sample preparation, makes a dramatic entry into the next-generation sequencing (NGS) applications market with the strategic addition of a team of experts in NGS, the opening of a new Seattle research facility, and — by year's end — the launch of a simplified sample preparation kit capable of working from reduced starting material for next-generation RNA-Seq.
› Verified 5 days ago
Dr. James I Wax, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Drive Suite 210, Bellevue, NE 68005 Phone: 402-292-5594 Fax: 402-292-5832 | |
Dr. Joseph S Miller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1902 Harlan Dr, Bellevue, NE 68005 Phone: 402-682-4165 Fax: 402-934-2291 | |
Dr. Jeremy C King, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 Fax: 402-595-1970 | |
Holly Lynn Groteluschen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 | |
Brian J Finley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr, Ste 145a, Bellevue, NE 68123 Phone: 402-779-7207 Fax: 402-779-7210 | |
Kevin B Jones, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3308 Samson Way Ste 102, Bellevue, NE 68123 Phone: 402-291-3373 | |
Dr. Khalil John Burhan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3308 Samson Way, Bellevue, NE 68123 Phone: 402-827-1577 Fax: 402-898-3134 |